Kawata S - Search Results

1

Lack of frameshift mutations at coding mononucleotide repeats in hepatocellular carcinoma in Japanese patients.

Saeki A, Tamura S, Ito N, Kiso S, Matsuda Y, Yabuuchi I, Kawata S, Matsuzawa Y. Saeki A, et al. Among authors: kawata s. Cancer. 2000 Mar 1;88(5):1025-9. Cancer. 2000. PMID: 10699890

2

Frequent impairment of the spindle assembly checkpoint in hepatocellular carcinoma.

Saeki A, Tamura S, Ito N, Kiso S, Matsuda Y, Yabuuchi I, Kawata S, Matsuzawa Y. Saeki A, et al. Among authors: kawata s. Cancer. 2002 Apr 1;94(7):2047-54. doi: 10.1002/cncr.10448. Cancer. 2002. PMID: 11932908 Free article.

3

Elevated levels of plasma transforming growth factor-beta in patients with hepatocellular carcinoma.

Shirai Y, Kawata S, Ito N, Tamura S, Takaishi K, Kiso S, Tsushima H, Matsuzawa Y. Shirai Y, et al. Among authors: kawata s. Jpn J Cancer Res. 1992 Jul;83(7):676-9. doi: 10.1111/j.1349-7006.1992.tb01964.x. Jpn J Cancer Res. 1992. PMID: 1325427 Free PMC article.

4

Elevated levels of transforming growth factor beta messenger RNA and its polypeptide in human hepatocellular carcinoma.

Ito N, Kawata S, Tamura S, Takaishi K, Shirai Y, Kiso S, Yabuuchi I, Matsuda Y, Nishioka M, Tarui S. Ito N, et al. Among authors: kawata s. Cancer Res. 1991 Aug 1;51(15):4080-3. Cancer Res. 1991. PMID: 1649698

5

Expression of transforming growth factor-beta 1 mRNA in human hepatocellular carcinoma.

Ito N, Kawata S, Tamura S, Takaishi K, Yabuuchi I, Matsuda Y, Nishioka M, Tarui S. Ito N, et al. Among authors: kawata s. Jpn J Cancer Res. 1990 Dec;81(12):1202-5. doi: 10.1111/j.1349-7006.1990.tb02678.x. Jpn J Cancer Res. 1990. PMID: 1703520 Free PMC article.

6

Increase in the active form of 3-hydroxy-3-methylglutaryl coenzyme A reductase in human hepatocellular carcinoma: possible mechanism for alteration of cholesterol biosynthesis.

Kawata S, Takaishi K, Nagase T, Ito N, Matsuda Y, Tamura S, Matsuzawa Y, Tarui S. Kawata S, et al. Cancer Res. 1990 Jun 1;50(11):3270-3. Cancer Res. 1990. PMID: 2159376

7

Modulation of c-myc expression by transforming growth factor beta 1 in human hepatoma cell lines.

Ito N, Kawata S, Tamura S, Takaishi K, Saitoh R, Tarui S. Ito N, et al. Among authors: kawata s. Jpn J Cancer Res. 1990 Mar;81(3):216-9. doi: 10.1111/j.1349-7006.1990.tb02552.x. Jpn J Cancer Res. 1990. PMID: 2161812 Free PMC article.

8

Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases.

Shirai Y, Kawata S, Tamura S, Ito N, Tsushima H, Takaishi K, Kiso S, Matsuzawa Y. Shirai Y, et al. Among authors: kawata s. Cancer. 1994 May 1;73(9):2275-9. doi: 10.1002/1097-0142(19940501)73:9<2275::aid-cncr2820730907>3.0.co;2-t. Cancer. 1994. PMID: 7513247

9

Positive correlation of plasma transforming growth factor-beta 1 levels with tumor vascularity in hepatocellular carcinoma.

Ito N, Kawata S, Tamura S, Shirai Y, Kiso S, Tsushima H, Matsuzawa Y. Ito N, et al. Among authors: kawata s. Cancer Lett. 1995 Feb 10;89(1):45-8. doi: 10.1016/0304-3835(95)90156-6. Cancer Lett. 1995. PMID: 7882301

10

Interleukin-6 in transcatheter arterial embolization for patients with hepatocellular carcinoma. Effects of serine protease inhibitor.

Matsuda Y, Kawata S, Nagase T, Maeda Y, Yamasaki E, Kiso S, Ishiguro H, Matsuzawa Y. Matsuda Y, et al. Among authors: kawata s. Cancer. 1994 Jan 1;73(1):53-7. doi: 10.1002/1097-0142(19940101)73:1<53::aid-cncr2820730111>3.0.co;2-w. Cancer. 1994. PMID: 8275438 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

846 results

Search Page

Filters